- Home
- TBNK vs ALRN Comparison
TBNK vs ALRN Comparison
Compare TBNK & ALRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBNK
- ALRN
- Stock Information
- Founded
- TBNK 1921
- ALRN 2001
- Country
- TBNK United States
- ALRN United States
- Employees
- TBNK N/A
- ALRN N/A
- Industry
- TBNK Savings Institutions
- ALRN Biotechnology: Pharmaceutical Preparations
- Sector
- TBNK Finance
- ALRN Health Care
- Exchange
- TBNK Nasdaq
- ALRN Nasdaq
- Market Cap
- TBNK 70.7M
- ALRN 76.9M
- IPO Year
- TBNK N/A
- ALRN 2017
- Fundamental
- Price
- TBNK $8.98
- ALRN $1.97
- Analyst Decision
- TBNK Hold
- ALRN Strong Buy
- Analyst Count
- TBNK 2
- ALRN 1
- Target Price
- TBNK $9.89
- ALRN $19.00
- AVG Volume (30 Days)
- TBNK 24.8K
- ALRN 137.2K
- Earning Date
- TBNK 01-28-2025
- ALRN 11-14-2024
- Dividend Yield
- TBNK 0.45%
- ALRN N/A
- EPS Growth
- TBNK N/A
- ALRN N/A
- EPS
- TBNK N/A
- ALRN N/A
- Revenue
- TBNK $36,203,000.00
- ALRN N/A
- Revenue This Year
- TBNK N/A
- ALRN N/A
- Revenue Next Year
- TBNK $8.07
- ALRN N/A
- P/E Ratio
- TBNK N/A
- ALRN N/A
- Revenue Growth
- TBNK N/A
- ALRN N/A
- 52 Week Low
- TBNK $6.92
- ALRN $1.61
- 52 Week High
- TBNK $11.60
- ALRN $7.42
- Technical
- Relative Strength Index (RSI)
- TBNK 31.86
- ALRN 41.44
- Support Level
- TBNK $8.96
- ALRN $1.90
- Resistance Level
- TBNK $9.39
- ALRN $2.17
- Average True Range (ATR)
- TBNK 0.25
- ALRN 0.18
- MACD
- TBNK -0.02
- ALRN 0.02
- Stochastic Oscillator
- TBNK 18.87
- ALRN 23.27
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.